Genesis Biotechnology completes nearly 200 million yuan Series B financing.

On September 2, Qiyuan Biotechnology Co., Ltd. announced the completion of nearly 200 million yuan in Series B financing. This round of financing was led by Fuzhou Capital Fund, with Honghui Fund, Hangzhou Manufacturing Investment Group, and two professional investors participating in the follow-up investment.